These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31441050)

  • 1. Public Health Risk of Designer Psychotropic Drugs: Should PHASE Be Phased In?
    Greenblatt DJ
    Clin Pharmacol Ther; 2019 Dec; 106(6):1175-1176. PubMed ID: 31441050
    [No Abstract]   [Full Text] [Related]  

  • 2. New and Emerging Illicit Psychoactive Substances.
    Graddy R; Buresh ME; Rastegar DA
    Med Clin North Am; 2018 Jul; 102(4):697-714. PubMed ID: 29933824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review.
    Armenian P; Vo KT; Barr-Walker J; Lynch KL
    Neuropharmacology; 2018 May; 134(Pt A):121-132. PubMed ID: 29042317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro characterization of new psychoactive substances at the μ-opioid, CB1, 5HT
    Åstrand A; Guerrieri D; Vikingsson S; Kronstrand R; Green H
    Forensic Sci Int; 2020 Dec; 317():110553. PubMed ID: 33160102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel psychoactive substances.
    Krabseth HM; Tuv SS; Strand MC; Karinen RA; Wiik E; Vevelstad MS; Westin AA; Øiestad EL; Vindenes V
    Tidsskr Nor Laegeforen; 2016 May; 136(8):714-7. PubMed ID: 27143461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designer drugs 2015: assessment and management.
    Weaver MF; Hopper JA; Gunderson EW
    Addict Sci Clin Pract; 2015 Mar; 10(1):8. PubMed ID: 25928069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designer Benzodiazepines: Another Class of New Psychoactive Substances.
    Moosmann B; Auwärter V
    Handb Exp Pharmacol; 2018; 252():383-410. PubMed ID: 30367253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report of Increasing Overdose Deaths that include Acetyl Fentanyl in Multiple Counties of the Southwestern Region of the Commonwealth of Pennsylvania in 2015-2016.
    Dwyer JB; Janssen J; Luckasevic TM; Williams KE
    J Forensic Sci; 2018 Jan; 63(1):195-200. PubMed ID: 28605020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deconstructing Designer Drugs.
    Sellers EM
    Clin Pharmacol Ther; 2017 Feb; 101(2):167-169. PubMed ID: 27564430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schedules of Controlled Substances: Temporary Placement of Acetyl Fentanyl Into Schedule I. Final order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2015 Jul; 80(137):42381-5. PubMed ID: 26189217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designer Drug (DD) abuse in Poland; a review of the psychoactive and toxic properties of substances found from seizures of illegal drug products and the legal consequences thereof. Part 1--cannabinoids and cathinones.
    Biliński P; Hołownia P; Kapka-Skrzypczak L; Wojtyła A
    Ann Agric Environ Med; 2012; 19(4):857-70. PubMed ID: 23311820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designer drugs: a medicinal chemistry perspective.
    Carroll FI; Lewin AH; Mascarella SW; Seltzman HH; Reddy PA
    Ann N Y Acad Sci; 2012 Feb; 1248():18-38. PubMed ID: 22092008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving.
    Zubieta JK; Gorelick DA; Stauffer R; Ravert HT; Dannals RF; Frost JJ
    Nat Med; 1996 Nov; 2(11):1225-9. PubMed ID: 8898749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid Overdose Outbreak - West Virginia, August 2016.
    Massey J; Kilkenny M; Batdorf S; Sanders SK; Ellison D; Halpin J; Gladden RM; Bixler D; Haddy L; Gupta R
    MMWR Morb Mortal Wkly Rep; 2017 Sep; 66(37):975-980. PubMed ID: 28934186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food".
    Coppola M; Mondola R
    Toxicol Lett; 2012 Jun; 211(2):144-9. PubMed ID: 22459606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Synthetic Opioid Involvement in Drug Overdose Deaths in the United States, 2010-2016.
    Jones CM; Einstein EB; Compton WM
    JAMA; 2018 May; 319(17):1819-1821. PubMed ID: 29715347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An outbreak of designer drug--related deaths in Pennsylvania.
    Hibbs J; Perper J; Winek CL
    JAMA; 1991 Feb; 265(8):1011-3. PubMed ID: 1867667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designer Drugs 2.0.
    Huestis MA; Tyndale RF
    Clin Pharmacol Ther; 2017 Feb; 101(2):152-157. PubMed ID: 28084644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DARK Classics in Chemical Neuroscience: Fentanyl.
    Burns SM; Cunningham CW; Mercer SL
    ACS Chem Neurosci; 2018 Oct; 9(10):2428-2437. PubMed ID: 29894151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fentanyl-related designer drugs W-18 and W-15 lack appreciable opioid activity in vitro and in vivo.
    Huang XP; Che T; Mangano TJ; Le Rouzic V; Pan YX; Majumdar S; Cameron MD; Baumann MH; Pasternak GW; Roth BL
    JCI Insight; 2017 Nov; 2(22):. PubMed ID: 29202454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.